Publications

You can use the filters to show only results that match your interests

Filter publications
380 publications by Medicines and Healthcare products Regulatory Agency ×
Get updates to this list email feed

Copy and paste this URL in to your feed reader

  1. Advertising investigations: February 2018

  2. Marketing authorisations granted in March 2018

  3. Parallel import licenses granted in March 2018

  4. Human and veterinary medicines: register of licensed manufacturing sites

  5. Human and veterinary medicines: register of licensed wholesale distribution sites

  6. Suspended and revoked licences and registrations for manufacturers and wholesalers of medicines and ingredients

  7. Medicines: new manufacturing and wholesale dealer licences

  8. Register of brokers authorised to deal in human medicines

  9. Medicines: terminated and cancelled manufacturing and wholesale dealer licences

  10. Early access to medicines scheme applications: pending, refused, granted

    • MHRA
    • Official Statistics
  11. Medicines: licensing time-based performance measures

    • MHRA
    • Official Statistics
  12. Advertising investigations: January 2018

  13. Early access to medicines scheme (EAMS) scientific opinion: Volanesorsen as a treatment of adult patients with familial chylomicronaemia syndrome

  14. Common issues identified during clinical trial applications

    • MHRA
    • Guidance
  15. Marketing authorisations granted in February 2018

  16. Parallel import licenses granted in February 2018

  17. Medicines and Healthcare products Regulatory Agency board member expenses from July to September 2016

    • MHRA
    • Transparency data
  18. Medicines and Healthcare products Regulatory Agency board member expenses from July to September 17

    • MHRA
    • Transparency data
  19. Medicines and Healthcare products Regulatory Agency board member expenses from April to June 2017

    • MHRA
    • Transparency data
  20. Medicines and Healthcare products Regulatory Agency board member expenses from October to December 2017

    • MHRA
    • Transparency data
  21. Medicines and Healthcare products Regulatory Agency board member expenses from January to March 2017

    • MHRA
    • Transparency data
  22. Medicines and Healthcare products Regulatory Agency board member expenses from October to December 2016

    • MHRA
    • Transparency data
  23. Guidance on GxP data integrity

    • MHRA
    • Guidance
  24. MHRA: requests under the Freedom of Information Act (FOIA)

    • MHRA
    • FOI release
  25. Clinical trials for medicines: authorisation assessment performance

    • MHRA
    • Transparency data
  26. Drug Safety Update: monthly PDF newsletter

    • MHRA
    • Guidance
  27. Blood bank compliance report template

    • MHRA
    • Form
  28. Early access to medicines scheme: expired scientific opinions

    • MHRA
    • Decision
  29. Herbal medicines granted a traditional herbal registration (THR)

  30. Parallel import licenses granted in January 2018

  31. Marketing authorisations granted in January 2018

  32. Out-of-specification investigations

    • MHRA
    • Guidance
  33. Advertising investigations: December 2017

  34. Medical devices: UK notified bodies

  35. Blood facility declaration form

    • MHRA
    • Form
  36. MHRA annual accountability review minutes

    • DHSC and MHRA
    • Transparency data
  37. Medicines and Healthcare products Regulatory Agency GPC spending over £500: 2017 - 2018

    • MHRA
    • Transparency data
  38. Medicines and Healthcare products Regulatory Agency GPC spending over £500: 2016 - 2017

    • MHRA
    • Transparency data
  39. Animal use in medicines and medical devices regulation

    • MHRA
    • Corporate report
  40. Health institution exemption for IVDR/MDR

    • MHRA
    • Open consultation